Home » Idenix May Drop Delayed Hepatitis C Drug for New Versions
Idenix May Drop Delayed Hepatitis C Drug for New Versions
Idenix Pharmaceuticals, a developer of hepatitis C drugs, may shelve experimental treatments currently on hold by U.S. regulators and focus on different versions, CEO Ron Renaud said.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May